NRSN – neurosense therapeutics ltd. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

NRSN

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/26

04:47 pm

nrsn

Form F-3 NeuroSense Therapeutics

Low Report

Form F-3 NeuroSense Therapeutics

Report

12/23

09:04 am

nrsn

Form 6-K NeuroSense Therapeutics For: Dec 23

High Report

Form 6-K NeuroSense Therapeutics For: Dec 23

Report

12/18

11:07 am

nrsn

Form 6-K NeuroSense Therapeutics For: Dec 18

Medium Report

Form 6-K NeuroSense Therapeutics For: Dec 18

Report

12/17

02:42 pm

nrsn

Form 6-K NeuroSense Therapeutics For: Dec 17

Medium Report

Form 6-K NeuroSense Therapeutics For: Dec 17

Report

12/13

06:03 am

nrsn

Form EFFECT NeuroSense Therapeutics

Medium Report

Form EFFECT NeuroSense Therapeutics

Report

12/12

05:09 pm

nrsn

Form 424B3 NeuroSense Therapeutics

Medium Report

Form 424B3 NeuroSense Therapeutics

Report

12/12

04:06 pm

nrsn

Form D NeuroSense Therapeutics

Medium Report

Form D NeuroSense Therapeutics

Report

12/11

09:28 am

nrsn

Form 6-K NeuroSense Therapeutics For: Dec 11

Medium Report

Form 6-K NeuroSense Therapeutics For: Dec 11

Report

12/9

04:00 pm

nrsn

Form SC 13G NeuroSense Therapeutics Filed by: Rimon Gold Assets Ltd

Neutral Report

Form SC 13G NeuroSense Therapeutics Filed by: Rimon Gold Assets Ltd

Report

12/6

04:31 pm

nrsn

Form F-3 NeuroSense Therapeutics

Low Report

Form F-3 NeuroSense Therapeutics

Report

12/4

08:33 am

nrsn

Form 6-K NeuroSense Therapeutics For: Dec 04

Medium Report

Form 6-K NeuroSense Therapeutics For: Dec 04

Report

12/2

04:16 pm

nrsn

Form 6-K NeuroSense Therapeutics For: Dec 02

Low Report

Form 6-K NeuroSense Therapeutics For: Dec 02

Report

11/25

06:30 am

nrsn

Form EFFECT NeuroSense Therapeutics

Low Report

Form EFFECT NeuroSense Therapeutics

Report

11/22

04:31 pm

nrsn

Form 424B3 NeuroSense Therapeutics

Low Report

Form 424B3 NeuroSense Therapeutics

Report

11/19

04:16 pm

nrsn

Form F-1 NeuroSense Therapeutics

High Report

Form F-1 NeuroSense Therapeutics

Report

11/12

09:49 am

nrsn

Form 6-K NeuroSense Therapeutics For: Nov 12

Low Report

Form 6-K NeuroSense Therapeutics For: Nov 12

Report

10/31

05:00 pm

nrsn

Form 6-K NeuroSense Therapeutics For: Oct 31

Low Report

Form 6-K NeuroSense Therapeutics For: Oct 31

Report

10/30

09:45 am

nrsn

Form 6-K NeuroSense Therapeutics For: Oct 30

Low Report

Form 6-K NeuroSense Therapeutics For: Oct 30

Report

10/28

08:35 am

nrsn

Form 6-K NeuroSense Therapeutics For: Oct 28

Medium Report

Form 6-K NeuroSense Therapeutics For: Oct 28

Report

10/24

08:30 am

nrsn

Form 6-K NeuroSense Therapeutics For: Oct 24

Low Report

Form 6-K NeuroSense Therapeutics For: Oct 24

Report

10/15

09:36 am

nrsn

Form 6-K NeuroSense Therapeutics For: Oct 15

High Report

Form 6-K NeuroSense Therapeutics For: Oct 15

Report

10/9

09:13 am

nrsn

Form 6-K NeuroSense Therapeutics For: Oct 09

Low Report

Form 6-K NeuroSense Therapeutics For: Oct 09

Report

10/7

06:01 am

nrsn

Form EFFECT NeuroSense Therapeutics

Medium Report

Form EFFECT NeuroSense Therapeutics

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.